Arvinas and Pfizer complete Rigel license deal for vepdegestrant
Go back to Arvinas and Pfizer complete Rigel license deal for vepdegestrant| (NASDAQ: ARVN) | Delayed: 7.34 +0.04 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.30 | 52 Week High | $ | |||
| Open | $7.32 | 52 Week Low | $ | |||
| Day High | $7.38 | P/E | N/A | |||
| Day Low | $7.31 | EPS | $ | |||
| Volume | 10,488 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 30.21 +0.18 (0.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $30.03 | 52 Week High | $37.39 | |||
| Open | $30.00 | 52 Week Low | $28.25 | |||
| Day High | $30.31 | P/E | 18.31 | |||
| Day Low | $29.96 | EPS | $1.65 | |||
| Volume | 1,200,709 | |||||



